Gartlehner G, Gaynes BN.

Danube University, Department for Evidence-based Medicine and Clinical Epidemiology, Krems, Austria. gerald.gartlehner@donau-uni.ac.at

Primary care physicians and psychiatrists manage the majority of patients suffering from acute phase major depressive disorder (MDD). For most patients, antidepressant treatment is the primary choice of care. Second generation antidepressants (SGAs)—developed following the first generation of tricyclic and monoamine oxidase agents—have become the preferred drug choice because of their greater tolerability, lower risk of lethality and similar efficacy compared with first generation agents. (More)

Garner BR.

Chestnut Health Systems, 448 Wylie Dr., Normal, IL 61761, USA. brgarner@chestnut.org

This article provides a comprehensive review of research studies that have examined the diffusion of evidence-based treatments (EBTs) within the field of substance abuse treatment. (More)

Donohue B, Allen DN, Romero V, Hill HH, Vasaeli K, Lapota H, Tracy K, Gorney S, Abdel-al R, Caldas D, Herdzik K, Bradshaw K, Valdez R, Van Hasselt VB.

Department of Psychology, University of Nevada Las Vegas, Las Vegas, NV, USA. bradley.donohue@unlv.edu

Developers of evidence-based therapies are enhancing methods of teaching therapists to implement “best practices” with integrity. However, there is a relative dearth of information available as to clinic operations and related contextual factors necessary to sustain successful implementation of these treatments. (More)

Jewell TC, Downing D, McFarlane WR.

Coordinated Care Services, Inc. (CCSI), Evaluation and Services Research, 1099 Jay Street, Building J-3rd Floor, Rochester, NY 14611, USA. tjewell@ccsi.org

Family psychoeducation (FPE) is one of six evidence-based practices endorsed by the Center for Mental Health Services for individuals suffering from chronic mental illnesses. Multiple family group psychoeducation (MFG) has been shown to be an effective component of FPE in reducing symptom relapses and rehospitalizations for individuals with schizophrenia. (More)

Levitt JM.

Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. LevittJ@childpsych.columbia.edu

Despite the recognized importance of mental health concerns among youth in the child welfare population, data suggest a significant gap between children who need services and children who receive services. This paper aims to address this problem by focusing on the ways in which the system identifies–or fails to identify–children as needing mental health services. (More)

Goodwin GM; Consensus Group of the British Association for Psychopharmacology.Collaborators (30)

Chandler S, Anderson I, Colom F, Coghill D, Cookson J, Ferrier N, Geddes J, Goodwin G, Haddad P, Hunt N, Kapur N, Jones I, Lam D, Lingford-Hughes A, Miklowitz D, Morriss R, Sahakian B, Scott J, Taylor D, Thakore J, Thapar A, Thomas A, McGuire P, Cooper S, Cowen P, Manning C, Ebmeier K, Cavanagh J, Barnes T, Aitchison KJ.

University Department of Psychiatry, Warneford Hospital, Oxford, UK.

The British Association for Psychopharmacology guidelines specify the scope and target of treatment for bipolar disorder. The second version, like the first, is based explicitly on the available evidence and presented, like previous Clinical Practice guidelines, as recommendations to aid clinical decision making for practitioners: they may also serve as a source of information for patients and carers. (More)

Brent DA, Maalouf FT.

University of Pittsburgh Medical Center, 200 Lothrop St., Pittsburgh, PA 15213-2582, USA. sughrueb@upmc.edu

Although there have been advances in our ability to treat child and adolescent depression, use of evidence-based treatments still results in many patients with residual symptoms. Advances in our understanding of cognitive, emotional, and ecological aspects of early-onset depression have the potential to lead to improvements in the assessment and treatment of depression. (More)

Ravindran AV, da Silva TL, Ravindran LN, Richter MA, Rector NA.

University of Toronto, Ontario, Canada. arun_ravindran@camh.net

OBJECTIVE: To provide a review of the evidence-based treatments for obsessive-compulsive spectrum disorders (OCSD), a group of conditions related to obsessive-compulsive disorder (OCD) by phenomenological and etiological similarities, the morbidity of which is increasingly recognized. (More)

Parks JJ.

Department of Psychiatry, University of Missouri-Columbia and the Missouri Department of Mental Health, Jefferson City, Mo, USA. prksjo@centurytel.net

There is evidence that state-of-the-art psychiatric treatments are not being translated into community settings, resulting in the de facto denial of up-to-date psychiatric care for many Americans with mental illness. Although multiple models of evidence-based care exist, little is known about how to disseminate information regarding these models to clinicians in real-world practice. (More)

Grandjean EM, Aubry JM.

Phidalsa Institute for Clinical Investigation, Geneva, Switzerland.

Although there has been a decrease in lithium use over several years, it is still recommended as a first-line mood stabilizer in all recent guidelines. It has been argued that many studies of lithium were conducted at a time when study design, assessment standards and the diagnostic criteria for patient selection were not as established as they presently are. However, recent placebo-controlled data from three-arm trials have demonstrated a definite efficacy of lithium in bipolar disorder. (More)